Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

98.95
Delayed Data
As of Nov 20
 -6.52 / -6.18%
Today’s Change
98.49
Today|||52-Week Range
153.15
-1.32%
Year-to-Date

Today’s Trading

Previous close105.47
Today’s open105.29
Day’s range98.72 - 106.95
Volume2,526,727
Average volume (3 months)1,591,235
Market cap$22.3B
Dividend yield--
Data as of 4:00pm ET, 11/20/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)-329.18%
Earnings growth (next 5 years)+75.95%
Revenue growth (last year)+46.70%
P/E ratioNM
Price/Sales17.60
Price/Book47.48

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.16+0.23%
ALXNAlexion Pharmaceutic...-2.38-2.15%
BAXBaxter International...0.000.00%
MYLMylan NV-1.09-2.90%
Data as of 4:15pm ET, 11/20/2017

Financials

Next reporting dateFebruary 14, 2018
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts